Trulieve Cannabis (NYSE: TRLV) net income
Trulieve Cannabis reported a net loss of $122.2m for fiscal 2025; in fiscal 2024 it reported a net loss of $160.6m. Earnings per share were −$0.58.
Trulieve Cannabis's best year of the last 6 was fiscal 2020. The biggest drop was in fiscal 2021, −72.3%. It reported a loss in 4 of those 6 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$122.2m | — | −10.3% | −$0.58 |
| 2024 | −$160.6m | — | −13.5% | −$0.79 |
| 2023 | −$533.1m | — | −47.2% | −$2.28 |
| 2022 | −$252.7m | −1,548.7% | −20.7% | −$1.06 |
| 2021 | $17.4m | −72.3% | 1.9% | $0.13 |
| 2020 | $63.0m | — | 12.1% | $0.55 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Trulieve Cannabis net income compared with its sector
By net income for its latest fiscal year, Trulieve Cannabis ranks 358th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Trulieve Cannabis, −10.3%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 356th | Acumen Pharmaceuticals | −$121.3m | — |
| 357th | Tilray Brands | −$121.4m | −13.3% |
| 358th | Trulieve Cannabis | −$122.2m | −10.3% |
| 359th | Tonix Pharmaceuticals | −$124.0m | −946.2% |
| 360th | Erasca | −$124.5m | — |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Trulieve Cannabis
- How much did Trulieve Cannabis earn in fiscal 2025?
- Trulieve Cannabis reported a net loss of $122.2m for fiscal 2025. In fiscal 2024 it reported a net loss of $160.6m.
- What are the earnings per share of Trulieve Cannabis?
- They were −$0.58 in fiscal 2025, compared with −$0.79 in fiscal 2024.
- What was the most profitable year for Trulieve Cannabis?
- Of its last 6 fiscal years, fiscal 2020, with $63.0m.
- Where does Trulieve Cannabis rank in its sector by net income?
- It ranks 358th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Trulieve Cannabis come from?
- From the annual report (Form 10-K) that Trulieve Cannabis files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Trulieve Cannabis files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on Trulieve Cannabis: the Trulieve Cannabis page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.